These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31890671)

  • 1. The effect of
    Rashidmayvan M; Mohammadshahi M; Seyedian SS; Haghighizadeh MH
    J Diabetes Metab Disord; 2019 Dec; 18(2):453-459. PubMed ID: 31890671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Nigella sativa in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Tang G; Zhang L; Tao J; Wei Z
    Phytother Res; 2021 Aug; 35(8):4183-4193. PubMed ID: 33728708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
    Nutr Metab (Lond); 2019; 16():8. PubMed ID: 30705687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial.
    Khonche A; Huseini HF; Gholamian M; Mohtashami R; Nabati F; Kianbakht S
    J Ethnopharmacol; 2019 Apr; 234():106-111. PubMed ID: 30639231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Ginger Powder Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.
    Rafie R; Hosseini SA; Hajiani E; Saki Malehi A; Mard SA
    Clin Exp Gastroenterol; 2020; 13():35-45. PubMed ID: 32158249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nigella sativa and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Results from a randomized, double-blind, placebo-controlled, clinical trial.
    Darand M; Darabi Z; Yari Z; Saadati S; Hedayati M; Khoncheh A; Hosseini-Ahangar B; Alavian SM; Hekmatdoost A
    Complement Ther Med; 2019 Jun; 44():204-209. PubMed ID: 31126557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.
    Moradi F; Kooshki F; Nokhostin F; Khoshbaten M; Bazyar H; Pourghassem Gargari B
    J Trace Elem Med Biol; 2021 Jan; 63():126659. PubMed ID: 33045675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of nigella sativa supplementation on cardiometabolic outcomes in patients with non-alcoholic fatty liver: A randomized double-blind, placebo-controlled trial.
    Rashidmayvan M; Vandyousefi S; Barati M; Salamat S; Ghodrat S; Khorasanchi M; Jahan-Mihan A; Nattagh-Eshtivani E; Mohammadshahi M
    Complement Ther Clin Pract; 2022 Aug; 48():101598. PubMed ID: 35567872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
    Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
    Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Nigella sativa oil supplement on risk factors for cardiovascular diseases in patients with type 2 diabetes mellitus.
    Kooshki A; Tofighiyan T; Rastgoo N; Rakhshani MH; Miri M
    Phytother Res; 2020 Oct; 34(10):2706-2711. PubMed ID: 32510754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
    Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of omega-3-rich Camelina sativa on the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, controlled trial.
    Musazadeh V; Dehghan P; Khoshbaten M
    Eur J Gastroenterol Hepatol; 2022 May; 34(5):537-545. PubMed ID: 35421019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ameliorative Effect of Camel's Milk and
    Ahmad A; Al-Abbasi FA; Sadath S; Ali SS; Abuzinadah MF; Alhadrami HA; Mohammad Alghamdi AA; Aseeri AH; Khan SA; Husain A
    Pharmacogn Mag; 2018; 14(53):27-35. PubMed ID: 29576698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of
    Amizadeh S; Rashtchizadeh N; Khabbazi A; Ghorbanihaghjo A; Ebrahimi AA; Vatankhah AM; Malek Mahdavi A; Taghizadeh M
    Avicenna J Phytomed; 2020; 10(2):181-189. PubMed ID: 32257890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of sesame oil consumption compared to sunflower oil on lipid profile, blood pressure, and anthropometric indices in women with non-alcoholic fatty liver disease: a randomized double-blind controlled trial.
    Vahedi H; Atefi M; Entezari MH; Hassanzadeh A
    Trials; 2022 Jul; 23(1):551. PubMed ID: 35804451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Efficacy of
    Sadeghzadeh Z; Ostadrahimi A; Ranjbar M; Farshbaf-Khalili A
    J Caring Sci; 2023 Sep; 12(3):163-173. PubMed ID: 38020740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Nigella Sativa Oil on Oxidative Stress, Inflammatory, and Glycemic Control Indices in Diabetic Hemodialysis Patients: A Randomized Double-Blind, Controlled Trial.
    Rahmani A; Niknafs B; Naseri M; Nouri M; Tarighat-Esfanjani A
    Evid Based Complement Alternat Med; 2022; 2022():2753294. PubMed ID: 35463059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of sumac (Rhus coriaria L.) powder supplementation in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
    Kazemi S; Shidfar F; Ehsani S; Adibi P; Janani L; Eslami O
    Complement Ther Clin Pract; 2020 Nov; 41():101259. PubMed ID: 33190008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Nigella Sativa oil versus metformin on glycemic control and biochemical parameters of newly diagnosed type 2 diabetes mellitus patients.
    Moustafa HAM; El Wakeel LM; Halawa MR; Sabri NA; El-Bahy AZ; Singab AN
    Endocrine; 2019 Aug; 65(2):286-294. PubMed ID: 31152309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled clinical trial.
    Izadi F; Farrokhzad A; Tamizifar B; Tarrahi MJ; Entezari MH
    Phytother Res; 2021 Jan; 35(1):477-485. PubMed ID: 32909326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.